Traditional Chinese medicine preparation for treating mammary gland hyperplasia

A technology of mammary gland hyperplasia and traditional Chinese medicine, which is applied in the direction of medical preparations containing active ingredients, drug combinations, and pharmaceutical formulas, etc., which can solve problems such as unsatisfactory mammary gland hyperplasia effects, long-term use, and large side effects of western medicines

Pending Publication Date: 2021-04-30
0 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

However, this disease has the characteristics of periodicity and recurrent attacks. The above-mentioned western medicines have large side effects and cannot be taken for a long time.
[0005] At present, Chinese patent medicines for treating breast diseases mainly include Rujiling Granule...
View more


The invention relates to the technical field of pharmaceutical engineering, in particular to a traditional Chinese medicine preparation for treating hyperplasia of mammary glands. The pharmaceutical composition is prepared from radix bupleuri, radix paeoniae rubra, radix salviae miltiorrhizae, radix curcumae, spica prunellae, rhizoma cyperi, pericarpium citri reticulatae viride, murraya paniculata, radix angelicae sinensis, impatiens balsamina, livistona chinensis benth, herba ecliptae, lysimachia christinae hance, glechoma longituba and jasminum grandiflorum. Based on the principle of combining disease differentiation and syndrome differentiation of traditional Chinese medicine treatment of hyperplasia of mammary glands, the pharmaceutical composition treats both symptoms and root causes and treats both deficiency and excess, natural botanical drugs capable of soothing liver and regulating qi, softening hardness to dissipate stagnation, regulating Chong and Ren meridians and promoting blood circulation to arrest pain are screened out, and the pharmaceutical composition is precise and appropriate in drug combination, exact in curative effect, stable and low in cost. Through observation from the long-term and short-term clinical application process, no adverse reaction is generated.

Application Domain

Sexual disorderMagnoliophyta medical ingredients +1

Technology Topic

Mammary gland hyperplasiaCurcuma aromatica +20


  • Experimental program(1)

Example Embodiment

[0010]The following description will be further described below with reference to the present invention, and the following examples are intended to illustrate the invention, and the scope of the invention is not limiting.
[0011]A Chinese medicine combination for treating breast proliferation, the medicinal material used in accordance with the weight of the following weight: 5-18 pieces of Bupleurum, 5-18 red peony, 8-18 Danshen, 3-10 Tulips, 3-10 Blood grass 3-10 Sharp, 3-10 copies, 3-10 green skin, 3-10 parts of 9 miles, 5-15 degree of Angelica, 5-10 pieces of Fengxianhua, 3-10 sermbles, 5-15 bitter stone lotus, 5-15 red silk lines, 5-12 blood circulation Dan, 3-10 fraction of fractional flowers.
[0012]The number of pieces of the components in the Chinese medicine composition is more preferably: 12 parts of Chaihu, 10 red peony, 12 serviles, 10 tulips, 10 coprosion, 8 pieces, green skin 10 copies of 9 miles, 15 of Angelica, 8 pieces of Fengxianhua, 8 serumme, 5 servant, 8 red silk lines, 5 活 丹 丹, 5 servant.
[0013]Use the above drug to take a water; 1 dose per day, take 3 times a day, fifteen days for a course of treatment.
[0014]It is not limited to the preferred embodiments of the present invention, and the present invention is not limited to the above embodiments, and those skilled in the art will directly export or associate other improvements and changes in the premise of the spirit and conception of the present invention. It is considered contained within the scope of the invention.
[0015]Clinical use effect verification
[0016]First, general information
[0017]Among the 81 patients, age 23-56, the course of disease is not equal to 4 months to 8 years, and the average age is 32 years old.
[0018]Second, diagnostic criteria
[0019]Referring to the National Chinese Medicine Administration issued the "TCM Disease Diagnosis Efficacy Standard". (1) Periodic breast pain, more occurs or aggravates the early period of menstrual period. (2) Side or bilateral breasts, there is no size, strip-shaped or diffuse block, tough, boundary is independent, with a noduled nodulation, and no bonding with surrounding tissue. (3) Local skin is innocent, and the lymph nodes under the armpits are no swelling. (4) Mammary infrared line scanning, molybdenum target photograph, color multivajer ultrasound inspection or needle suction cell examination is diagnosed as breast hyperplasia.
[0020]Third, therapeutic method and the efficacy standard: patients taking the drugs of the invention, and takes 3 times a day. Five-day for a course of treatment.
[0021]Efficacy Standard: Referring to the efficacy standards formulated by the Chinese Medical Society Surgery
[0022]Cure: Breast massage and mafu disappear, no recurrence 3 months after stopping the drug.
[0023]Optimistic: The breast mass is reduced by more than 1/2, and the pain disappears.
[0024]Effective: The maximum diameter of the breast mass is less than 1/2, and the pain is reduced.
[0025]Invalid: The breast mass does not shrink, but it increases, hard, or simple matrix.
[0026]Fourth, experimental results:
[0027]After taking 3 courses, 81 patients were treated, 32 patients (39.5%), 9 (37.0%), effective in 15 cases (18.5%), 4 cases (5.0%), total effective rate of 95.0%. There was no adverse reactions during all patients.
[0028]V. Typical cases 1, 35 years old, summer, female, right breasts have a cake in 1 year, 2 months per month, hardening, hard; breast infrared line scan, color multi-tidal ultrasound examination about 4 × 5cm agglomeration, the boundary is indeed clear, has a tender, diagnosed as a breast hyperplasia. Taking the pharmaceutical combination of the present invention, 3 times a day, after 3 courses, the breast mass is reduced by more than 1/2, the pain is disappeared, and the treatment of 3 medications will consolidate the efficacy. The mass is basically disappeared, no tenderness, follow-up for half a year.


no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products